Kawasaki disease (KD), an acute self-limited febrile illness that primarily affects children <5 years old, is the leading cause of acquired heart disease in developed countries, with the potential of ...

Researchers from Johns Hopkins Medicine and Yale University have collaborated on the development and application of a ...

University of Wisconsin–Madison researchers targeting a group of hereditary neurodegenerative diseases have found success ...

A genomic test developed by researchers to rapidly detect almost any kind of pathogen -- virus, bacteria, fungus or parasite -- has proved successful after a decade of use.

The detailed structure of a misfolded protein from a diseased deer could help explain why the disease hasn’t made the leap to humans.

Patient-derived organoids (PDOs) are revolutionizing cancer research, enhancing drug testing and personalized treatment ...

Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today reported business highlights and third quarter 2024 financial results. "This is ...

Neurodegenerative diseases are a heterogeneous group of disorders ... tau secretion by lysosomal exocytosis without having a prion effect. This mechanism lowers intracellular tau and is ...

Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families ... offers Chronic Neuropathic ...

In a major discovery, scientists have presented the first evidence of Alzheimer's disease transmission in living individuals.

The National Prion Disease Pathology Surveillance Center (NPDPSC) is the only Center of its kind in the U.S., which coordinates autopsies and neuropathologic examinations of suspected prion disease ...

In Alzheimer’s, some research suggests that a buildup of prion proteins in the brain may contribute to the devastating loss of short- and long-term memory. “Long-term memory shapes our personality, ...